Showing results (21-30 of 123) with videos related to
Sort By:
Pageof 13
Trends in Molecular Medicine|June 16, 2005
NOD2 mutation and mice: no Crohn's disease but many lessons to learnJan Wehkamp, Eduard F StangeJournal of Molecular Medicine (Berlin, Germany)|December 19, 2016
Microbiome and chronic inflammatory bowel diseasesJan Wehkamp, Julia-Stefanie FrickF1000Research|February 7, 2017
Recent advances in understanding and managing Crohn's diseaseEduard F Stange, Jan WehkampInternational Journal of Medical Microbiology : IJMM|March 22, 2016
Crosstalk between microbiota, pathogens and the innate immune responsesClaudia Günther, Christine Josenhans, Jan WehkampCurrent Opinion in Gastroenterology|June 5, 2007
Defensins and other antimicrobial peptides in inflammatory bowel diseaseJan Wehkamp, Michael Schmid, Eduard F StangeCurrent Opinion in Gastroenterology|November 30, 2006
Defensins and cathelicidins in gastrointestinal infectionsJan Wehkamp, Jürgen Schauber, Eduard F StangeLangenbeck'S Archives of Surgery|November 20, 2012
Inflammatory bowel disease: an impaired barrier diseaseSimon Jäger, Eduard F Stange, Jan WehkampWorld Journal of Gastroenterology|September 14, 2011
From intestinal stem cells to inflammatory bowel diseasesMichael Gersemann, Eduard Friedrich Stange, Jan WehkampExpert Review of Clinical Immunology|September 11, 2010
Innate antimicrobial immunity in inflammatory bowel diseasesJulia Beisner, Eduard F Stange, Jan WehkampGut Microbes|June 4, 2011
Paneth cell function--implications in pediatric Crohn diseaseJulia Beisner, Eduard F Stange, Jan WehkampPageof 13